Tenalisib
- Product Name
- Tenalisib
- CAS No.
- 1639417-53-0
- Chemical Name
- Tenalisib
- Synonyms
- RP6530;Tenalisib;RP6530, Tenalisib;Tenalisib (RP6530);Tenalisib, 10 mM in DMSO;RP-6530; RP 6530; RP6530;Tenalisib (RP6530) ,S8672;Tenalisib (Synonyms: RP6530);alpha-2,3-Sialyltransferase (PmST1);Tenalisib,RP 6530,PI3K,Phosphoinositide 3-kinase,RP-6530,Inhibitor,inhibit
- CBNumber
- CB43054293
- Molecular Formula
- C23H18FN5O2
- Formula Weight
- 415.42
- MOL File
- 1639417-53-0.mol
Tenalisib Property
- Boiling point:
- 706.1±60.0 °C(Predicted)
- Density
- 1.434±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : ≥ 100 mg/mL (240.72 mM)
- form
- Solid
- pka
- 10.06±0.10(Predicted)
- color
- White to off-white
N-Bromosuccinimide Price
- Product number
- CS-6375
- Product name
- Tenalisib
- Purity
- 98.94%
- Packaging
- 10mg
- Price
- $290
- Updated
- 2021/12/16
- Product number
- CS-6375
- Product name
- Tenalisib
- Purity
- 98.94%
- Packaging
- 25mg
- Price
- $500
- Updated
- 2021/12/16
- Product number
- CS-6375
- Product name
- Tenalisib
- Purity
- 98.94%
- Packaging
- 50mg
- Price
- $890
- Updated
- 2021/12/16
- Product number
- CS-6375
- Product name
- Tenalisib
- Purity
- 98.94%
- Packaging
- 100mg
- Price
- $1500
- Updated
- 2021/12/16
- Product number
- CD11241930
- Product name
- Tenalisib
- Purity
- 95+%
- Packaging
- 10mg
- Price
- $230
- Updated
- 2021/12/16
Tenalisib Chemical Properties,Usage,Production
Uses
Tenalisib (RP6530) is a novel, potent, and selective PI3Kδ and PI3Kγ inhibitor with IC50 values of 25 and 33 nM, respectively.
in vivo
Tenalisib has been well tolerated in subjects with heavily pre-treated relapsed/refractory hematologic malignancies. Reported toxicities are manageable with no DLTs. Single agent activity is evident in difficult-to-treat subjects at ≥ 200 mg BID[2].
IC 50
PI3Kδ: 25 nM (IC50); PI3Kγ: 33 nM (IC50)
References
[1] Vakkalanka S, et al. RP6530, a dual PI3K δ/γ inhibitor, potentiates ruxolitinib activity in the JAK2-V617F mutant erythroleukemia cell lines. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2704. doi:10.1158/1538-7445.AM2015-2704
[2] Carmelo C, et al. A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic Malignancies. Blood 2015 126:1495;
Tenalisib Preparation Products And Raw materials
Raw materials
Preparation Products
Tenalisib Suppliers
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- 0371-55932928 18937192232
- Fax
- 0086-0371-55932928
- 1282296214@qq.com
- Country
- China
- ProdList
- 498
- Advantage
- 55
- Tel
- 18149758185 18149758185;
- sales-cpd@caerulumpharma.com
- Country
- China
- ProdList
- 3505
- Advantage
- 58
- Tel
- 400-400-164-7117 18317119277
- Fax
- +86-21-61629029
- product02@bidepharm.com
- Country
- China
- ProdList
- 40000
- Advantage
- 60
- Tel
- 028-81700200 18116577057
- Fax
- 028-81705658
- 3003855609@qq.com
- Country
- China
- ProdList
- 7778
- Advantage
- 56
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4800
- Advantage
- 55
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 021-QQ:65489617 15618227136
- Fax
- 21-5161 9052
- Sales@ATKchemical.com
- Country
- China
- ProdList
- 9531
- Advantage
- 58
- Tel
- 571-89925085
- Fax
- 0086-571-89925065
- sales@amadischem.com
- Country
- China
- ProdList
- 131957
- Advantage
- 58
- Tel
- 010-88886666-01 13112345678
- Fax
- CDXH21@126.com
- loyson@tcypharm.com
- Country
- China
- ProdList
- 597
- Advantage
- 55